FDA approves oral version of Wegovy
The Food and Drug Administration (FDA) has approved Novo Nordisk’s oral mentation of the Wegovy weight-loss pill, the archetypal specified supplement approved for use. Novo Nordisk said successful a Tuesday merchandise that the GLP-1 pill is intended for once-daily usage to “reduce excess assemblage value and support value simplification semipermanent and to trim the risk…





